These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7427564)

  • 1. Treatment of vasospastic disease with prostaglandin E1.
    Clifford PC; Martin MF; Sheddon EJ; Kirby JD; Baird RN; Dieppe PA
    Br Med J; 1980 Oct; 281(6247):1031-4. PubMed ID: 7427564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.
    Martin MF; Dowd PM; Ring EF; Cooke ED; Dieppe PA; Kirby JD
    Ann Rheum Dis; 1981 Aug; 40(4):350-4. PubMed ID: 7259326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E1 infusion for small vessel arterial ischaemia.
    Clifford PC; Martin MF; Dieppe PA; Sheddon EJ; Baird RN
    J Cardiovasc Surg (Torino); 1983; 24(5):503-8. PubMed ID: 6686232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E1 in severe Raynaud's phenomenon.
    Pardy BJ; Hoare MC; Eastcott HH; Miles CC; Needham TN; Harbourne T; Ellis BW
    Surgery; 1982 Dec; 92(6):953-65. PubMed ID: 6890719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis.
    Martin MF; Tooke JE
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1688-90. PubMed ID: 6816332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions.
    Langevitz P; Buskila D; Lee P; Urowitz MB
    J Rheumatol; 1989 Nov; 16(11):1433-5. PubMed ID: 2600942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 vasospastic disease and thermography.
    Kyle V; Parr G; Salisbury R; Thomas PP; Hazleman B
    Ann Rheum Dis; 1985 Feb; 44(2):73-8. PubMed ID: 3977414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.
    Wise RA; Wigley FM; White B; Leatherman G; Zhong J; Krasa H; Kambayashi J; Orlandi C; Czerwiec FS
    Arthritis Rheum; 2004 Dec; 50(12):3994-4001. PubMed ID: 15593189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of abnormal blood flow and efficacy of treatment in patients with systemic sclerosis using a newly developed microwireless laser Doppler flowmeter and arm-raising test.
    Kido M; Takeuchi S; Hayashida S; Urabe K; Sawada R; Furue M
    Br J Dermatol; 2007 Oct; 157(4):690-7. PubMed ID: 17640308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E1 therapy for digital ulcers in scleroderma.
    Baron M; Skrinskas G; Urowitz MB; Madras PN
    Can Med Assoc J; 1982 Jan; 126(1):42-5. PubMed ID: 7199370
    [No Abstract]   [Full Text] [Related]  

  • 12. Raynaud, digital ulcers and calcinosis in scleroderma.
    Nitsche A
    Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers.
    Bergersen TK; Hoffmann-Vold AM; Midtvedt Ø; Gran JT; Mørk C; Toska K; Elstad M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-53-9. PubMed ID: 24847906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon.
    Salsano F; Letizia C; Proietti M; Rossi C; Proietti AR; Rosato E; Pisarri S
    Int J Immunopathol Pharmacol; 2005; 18(4):761-70. PubMed ID: 16388726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension.
    Rosato E; Molinaro I; Borghese F; Rossi C; Pisarri S; Salsano F
    J Rheumatol; 2010 Dec; 37(12):2531-9. PubMed ID: 20810512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A new peripheral vasodilator prostaglandin E1 in atherosclerosis of lower limb vessels and Raynaud disease].
    Kirichenko AA; Novichkova IuN; Zubkova LV; Ter-Gevondian NM; Nenakhova TV
    Klin Med (Mosk); 1991 Nov; 69(11):40-3. PubMed ID: 1808404
    [No Abstract]   [Full Text] [Related]  

  • 20. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
    Finch MB; Dawson J; Johnston GD
    Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.